Biomerica, Inc.
BMRA
$2.38
-$0.02-0.63%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.19% | 40.68% | 16.81% | 23.61% | 7.83% |
| Total Depreciation and Amortization | 5.15% | 6.86% | 6.95% | 9.17% | 10.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.87% | -18.95% | -24.12% | -49.33% | 38.17% |
| Change in Net Operating Assets | 126.94% | -207.58% | 168.60% | 0.39% | -2,480.00% |
| Cash from Operations | 40.46% | 45.04% | 28.35% | 20.00% | 4.30% |
| Capital Expenditure | -- | -- | -- | 11.11% | 27.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.84% | -68.18% | 42.19% | 52.56% | 20.97% |
| Cash from Investing | 94.52% | 28.85% | 67.83% | 41.90% | 23.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 716.07% | -- | -- | -73.02% | -95.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.11% | 18.52% | 41.98% | 80.98% | 85.76% |
| Cash from Financing | 947.83% | 3,841.98% | 2,706.17% | -72.31% | -95.95% |
| Foreign Exchange rate Adjustments | 200.00% | 225.00% | -137.50% | -222.22% | 11.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.61% | 104.53% | 68.10% | -214.54% | -330.38% |